Risk of Hospitalization and Death for COVID ‐19 in People with Parkinson's Disease or Parkinsonism-Reference-Cited by-同舟云学术

Risk of Hospitalization and Death for COVID ‐19 in People with Parkinson's Disease or Parkinsonism

Published:2020-12-02 Issue:1 Volume:36 Page:1-10
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord

Author:

Vignatelli Luca¹^ORCID,Zenesini Corrado¹,Belotti Laura M.B.¹,Baldin Elisa¹,Bonavina Giuseppe²,Calandra‐Buonaura Giovanna¹³,Cortelli Pietro¹³^ORCID,Descovich Carlo⁴,Fabbri Giovanni⁴,Giannini Giulia¹³,Guarino Maria¹^ORCID,Pantieri Roberta¹,Samoggia Giuseppe⁴,Scaglione Cesa¹,Trombetti Susanna⁴,D'Alessandro Roberto¹,Nonino Francesco¹,

Affiliation:

1. IRCCS Istituto delle Scienze Neurologiche di Bologna Bologna Italy

2. Gruppo San Donato Bologna Italy

3. Università degli Studi di Bologna Dipartimento di Scienze Biomediche e NeuroMotorie Bologna Italy

4. AUSL di Bologna Bologna Italy

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mds.28408

Reference48 articles.

1. Global epidemiology of coronavirus disease 2019 (COVID-19): disease incidence, daily cumulative index, mortality, and their association with country healthcare resources and economic status

2. Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy

3. Covid-19 Outbreak Progression in Italian Regions: Approaching the Peak by the End of March in Northern Italy and First Week of April in Southern Italy

4. Ministero_della_Salute.https://github.com/pcm-dpc/COVID-19/blob/master/schede-riepilogative/regioni/dpc-covid19-ita-scheda-regioni-20200531.pdf. Last access October 27 2020.

5. AUSL_di_Bologna.https://public.tableau.com/profile/dsp.ausl.bologna#!/vizhome/ReportCovid-19AziendaUSLBologna31_05_2020mobile/ReportCovid-19AUSLBO31_05. Last access October 27 2020.

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. No genetic link between Parkinson’s disease and SARS-CoV-2 infection: a two-sample Mendelian randomization study;Frontiers in Neurology;2024-06-28

2. Beyond Code Status;New England Journal of Medicine;2024-04-25

3. Real-word immunogenicity of a recombinant subunit COVID-19 vaccine and effectiveness against omicron infection: a prospective, multi-centre, longitudinal cohort study in Alzheimer's disease patients;2024-04-02

4. Prevalence and Outcome of COVID-19 Among Parkinson’s Disease: A Report from Iran;Archives of Neuroscience;2024-03-18

5. Life and disease status of patients with Parkinson’s disease during and after zero-COVID in China: an online survey;Translational Neurodegeneration;2024-02-06